The Role of Pharmaco-mechanical Thrombectomy in Management of Acute Lower Extremity Arterial Ischemia
Sponsored by Assiut University
About this trial
Last updated a year ago
Study ID
PMT in acute limb ischemia
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started a year ago
What is this trial about?
The goal of our protocol is to re-establish patency in ALLI, by combining both balloon
maceration of a thrombus and angiojet PMT thus decreasing complications associated with
prolonged periods of thrombolytic exposure while avoid open surgical risk .
What are the participation requirements?
Inclusion Criteria
- Age ≥ 18 years - Symptom onset within 14 days for acute limb ischemia or within 30 days for subacute limb ischemia due to embolic or thrombotic occlusion of a native arteries, bypass graft, or arterial stent. Rutherford category I, IIa or IIb
Exclusion Criteria
- ALLI secondary to dissections, vasculitis, and/or target vessel trauma - Pregnancy or positive pregnancy test - Rutherford category III Irreversible (neglected) limb ischemia - patients allergic to contrast agent, - serum creatine>300 mmol/L